We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

AI Program Could Aid Decision-Making in Medical Imaging

By HospiMedica International staff writers
Posted on 24 Sep 2018
Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Researchers are developing a first of its kind neural network that explains itself and could help with decision-making in the medical field, among others. Raytheon BBN Technologies (Cambridge, MA, USA) is developing the neural network under the Defense Research Project Agency's (DARPA) Explainable Artificial Intelligence program (XAI). The aim of the XAI program is to create a suite of machine learning techniques, which produce more explainable models while maintaining a high level of performance. It also aims to help human users understand, appropriately trust and effectively manage the emerging generation of artificially intelligent partners.

The Explainable Question Answering System (EQUAS) by Raytheon BBN will allow Artificial Intelligence (AI) programs to 'show their work,' increasing the human user's confidence in the machine's suggestions. EQUAS will show users which data mattered most in the AI decision-making process. Using a graphical interface, users can explore the system's recommendations and see why it chose one answer over another. Although the technology is still in its early phases of development, it has the potential to be used for a wide-range of applications. As the system is enhanced, EQUAS will be able to monitor itself and share factors that limit its ability to make reliable recommendations. This self-monitoring capability will help developers refine AI systems, allowing them to inject additional data or change how data is processed.

"A fully developed system like EQUAS could help with decision-making not only in DoD operations, but in a range of other applications like campus security, industrial operations and the medical field," said Bill Ferguson, lead scientist and EQUAS principal investigator at Raytheon BBN. "Say a doctor has an x-ray image of a lung and her AI system says that its cancer. She asks why and the system highlights what it thinks are suspicious shadows, which she had previously disregarded as artifacts of the X-ray process. Now the doctor can make the call – to diagnose, investigate further, or, if she still thinks the system is in error, to let it go."

Related Links:
Raytheon BBN Technologies

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Medical Adhesive
MED 5570U

Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more